SCHEMBL7906252

SCHEMBL7906252

O=C(O)c1cc(C23CC4CC(CC(C4)C2)C3)cc(C23CC4CC(CC(C4)C2)C3)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RARB P10826 6/20 0.49
RARG P13631 6/20 0.49
RARA P10276 5/20 0.49
MEN1 O00255 5/20 0.46
KMT2A Q03164 5/20 0.46
POLB P06746 1/20 0.46
GAA P10253 1/20 0.46
GFER P55789 1/20 0.46
STS P08842 2/20 0.46
ALDH1A1 P00352 2/20 0.44
KDM4E B2RXH2 1/20 0.44
TP53 P04637 1/20 0.44
CYP3A4 P08684 1/20 0.44
MAPT P10636 1/20 0.44
HPGD P15428 1/20 0.44
ALOX15 P16050 1/20 0.44
ALOX12 P18054 1/20 0.44
MAPK1 P28482 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
HSD17B10 Q99714 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5834015 0.96 RARB (0.49) RARBRARGRARAMEN1KMT2A
SCHEMBL11549869 0.85 RARA (0.43) RARBRARGRARAMEN1KMT2A
SCHEMBL422675 0.82 SERPINE1 (0.58) RARBRARGRARAMEN1KMT2A
SCHEMBL28615868 0.81 MEN1 (0.46) RARBRARGRARAMEN1KMT2A
SCHEMBL422261 0.81 NPC1 (0.56) RARBRARGRARAMEN1KMT2A
Hydrochloric Acid SCHEMBL2710121 0.79 NPC1 (0.54) RARBRARGRARAMEN1KMT2A
SCHEMBL2709569 0.76 HIF1A (0.46) RARBRARGRARAMEN1KMT2A
SCHEMBL548788 0.75 MEN1 (0.57) RARBRARGRARAMEN1KMT2A
SCHEMBL3743458 0.75 SMN1; SMN2 (0.42) RARBRARGRARAMEN1KMT2A
SCHEMBL28289972 0.73 KMT2A (0.54) RARBRARGRARAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010034333-A1 Cyclodextrin polymer compositions for use as drug carriers KOSAK KENNETH M (US) 2001-10-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010034333-A1 Cyclodextrin polymer compositions for use as drug carriers ABCB1, ABCG2, CTTN RARB 4849/4885RARG 4763/4885RARA 4831/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.